Synaptogenix, Inc.
1185 Avenue of the Americas, 3rd Floor
New York, New York 10036
April 27, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
| Re: | Synaptogenix, Inc. | |
| Registration Statement on Form S-1 | ||
| File No. 333-252822 | ||
| Request for Acceleration |
Dear Mr. Gabor:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Synaptogenix, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-252822), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on April 29, 2021, or as soon thereafter as practicable.
Please call Daniel Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding this matter.
| Very truly yours, Synaptogenix, Inc. |
||||
| By: | /s/ Robert Weinstein | |||
| Name: | Robert Weinstein | |||
| Title: | Chief Financial Officer | |||
| cc: | Synaptogenix, Inc. |
Alan Tuchman, M.D.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Daniel A. Bagliebter, Esq.